Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12510379 | 0.86 | ALDH1A1 (0.37) | ALDH1A1LMNACYP3A4TDP1CTSK | |
| SCHEMBL11818004 | 0.81 | CYP3A4 (0.40) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL113867 | 0.80 | CYP3A4 (0.52) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL20819487 | 0.80 | CYP3A4 (0.52) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL11876408 | 0.77 | CYP3A4 (0.38) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL9011557 | 0.77 | CYP3A4 (0.38) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL22283429 | 0.76 | CYP1A2 (0.43) | ALDH1A1LMNACYP3A4TDP1CTSK | |
| SCHEMBL12044639 | 0.75 | CA1 (0.41) | ALDH1A1LMNACTSK | |
| Malonic Acid SCHEMBL10751042 | 0.75 | ALDH1A1 (0.49) | ALDH1A1LMNACYP3A4TDP1 | |
| SCHEMBL11766470 | 0.75 | CYP3A4 (0.36) | ALDH1A1LMNACYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025068206-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-03 | — | — | WO | claimed |
| WO-2025125532-A1 | PERFUME INGREDIENTS AND COMPOSITIONS CONTAINING THEM | GIVAUDAN SA (CH) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025068206-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-03 | — | — | WO | disclosed |
| EP-3230245-B1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FLAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2020-06-10 | — | — | EP | disclosed |
| US-10351797-B2 | Enamine and/or aminal fragrance precursors derived from (E/Z)-9-hydroxy-5,9-di-methyldec-4-enal | GIVAUDAN SA (CH) | 2019-07-16 | — | — | US | disclosed |
| US-10315976-B2 | Organic compounds | GIVAUDAN S.A. (CH) | 2019-06-11 | — | — | US | disclosed |
| EP-3230257-B1 | ENAMINE AND/OR AMINAL FRAGANCE PRECURSORS DERIVED FROM (E/Z)-9-HYDROXY-5,9-DIMETHYLDEC-4-ENAL | GIVAUDAN SA (CH) | 2019-04-03 | — | — | EP | disclosed |
| US-20170362533-A1 | ENAMINE AND/OR AMINAL FRAGRANCE PRECURSORS DERIVED FROM (E/Z)-9-HYDROXY-5,9-DI-METHYLDEC-4-ENAL | GIVAUDAN S.A. (CH) | 2017-12-21 | — | — | US | disclosed |
| EP-3230245-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FLAGRANCE INGREDIENTS | Givaudan SA (CH) | 2017-10-18 | — | — | EP | disclosed |
| EP-3230257-A1 | ENAMINE AND/OR AMINAL FRAGANCE PRECURSORS DERIVED FROM (E/Z)-9-HYDROXY-5,9-DIMETHYLDEC-4-ENAL | Givaudan SA (CH) | 2017-10-18 | — | — | EP | disclosed |
| WO-2016091894-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2016-06-16 | — | — | WO | disclosed |
| WO-2016091895-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FLAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2016-06-16 | — | — | WO | disclosed |
| US-20150307432-A1 | Improvements In or Relating to Organic Compounds | GIVAUDAN S.A. (CH) | 2015-10-29 | — | — | US | disclosed |
| EP-2920139-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2015-09-23 | — | — | EP | disclosed |
| WO-2014198709-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2014-12-18 | — | — | WO | disclosed |
| EP-2172118-A2 | Fluid compositions comprising polyphenols and methods for making and packaging the same | IdeaMed LLC (US) | 2010-04-07 | — | — | EP | disclosed |
| EP-2035538-A2 | FLUID COMPOSITIONS COMPRISING POLYPHENOLS AND METHODS FOR MAKING AND PACKAGING THE SAME | IdeaMed LLC (US) | 2009-03-18 | — | — | EP | disclosed |
| US-20080213433-A1 | Fluid compositions comprising polyphenols and methods for making and packaging the same | ATLA HOLDINGS, LLC | 2008-09-04 | — | — | US | disclosed |
| WO-2007146318-A9 | FLUID COMPOSITIONS COMPRISING POLYPHENOLS AND METHODS FOR MAKING AND PACKAGING THE SAME | ATLA HOLDINGS LLC (US) | 2008-03-13 | — | — | WO | disclosed |
| WO-2007146318-A2 | FLUID COMPOSITIONS COMPRISING POLYPHENOLS AND METHODS FOR MAKING AND PACKAGING THE SAME | IDEAMED LLC (US) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362533-A1 | ENAMINE AND/OR AMINAL FRAGRANCE PRECURSORS DERIVED FROM (E/Z)-9-HYDROXY-5,9-DI-METHYLDEC-4-ENAL | HNMT, DRD5, H1-5 | ALDH1A1 304/4885LMNA 968/4885CYP3A4 443/4885 |
| US-10351797-B2 | Enamine and/or aminal fragrance precursors derived from (E/Z)-9-hydroxy-5,9-di-methyldec-4-enal | HNMT, DRD5, H1-5 | ALDH1A1 304/4885LMNA 968/4885CYP3A4 443/4885 |
| US-20150307432-A1 | Improvements In or Relating to Organic Compounds | CYP11B2, UGT1A9, CYP11B1 | ALDH1A1 69/4885LMNA 1286/4885CYP3A4 38/4885 |
| US-10315976-B2 | Organic compounds | CYP2C9, UGT1A9, CYP3A4 | ALDH1A1 40/4885LMNA 911/4885CYP3A4 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.